We currently do not have sufficient information about the CEO.
Key information
Jonathan Dickinson
Chief executive officer
€939.6k
Total compensation
CEO salary percentage
58.53%
CEO tenure
1.6yrs
CEO ownership
n/a
Management average tenure
2.4yrs
Board average tenure
1.1yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Jonathan Dickinson's remuneration changed compared to Innate Pharma's earnings?
Date
Total Compensation
Salary
Company Earnings
Dec 31 2025
€940k
€550k
-€49m
Sep 30 2025
n/a
n/a
-€48m
Jun 30 2025
n/a
n/a
-€46m
Mar 31 2025
n/a
n/a
-€48m
Dec 31 2024
€435k
€92k
-€49m
Compensation vs Market: Jonathan's total compensation ($USD1.10M) is above average for companies of similar size in the German market ($USD797.36K).
Compensation vs Earnings: Jonathan's compensation has increased whilst the company is unprofitable.
CEO
Jonathan Dickinson (58 yo)
1.6yrs
Tenure
€939,625
Compensation
Mr. Jonathan E. Dickinson, MBA, BSc served as Executive Vice President and General Manager of Europe at Incyte Corp. since June 2019 until October 2024. Mr. Dickinson is Chief Executive Officer of Innate P...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Jonathan Dickinson
CEO & Director
1.6yrs
€939.63k
no data
Yannis Morel
Executive VP & COO
2.4yrs
€163.69k
0.40% € 603.2k
Sonia Quaratino
Executive VP & Chief Medical Officer
1.4yrs
€188.14k
no data
François Romagné
Founder
no data
no data
no data
Marc Bonneville
Founder
no data
no data
no data
Jean Fournié
Founder
no data
no data
no data
Alessandro Moretta
Founder
no data
no data
no data
Frederic Lombard
Senior VP & CFO
5.2yrs
no data
0.080% € 121.1k
Stephanie Cornen
Vice President of Investor Relations
1.4yrs
no data
0.032% € 47.7k
Odile Belzunce
VP, Chief of Compliance & Operations Officer and Interim Head of HR
7.4yrs
no data
0.15% € 219.6k
Claire de Blanquat
VP of Legal & Corporate Affairs and Secretary of the Supervisory Board
3.4yrs
no data
0.054% € 81.7k
2.4yrs
Average Tenure
53yo
Average Age
Experienced Management: IDD's management team is considered experienced (2.4 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Jonathan Dickinson
CEO & Director
1.1yrs
€939.63k
no data
Olivier Martinez
Director
1.1yrs
no data
no data
Christian Itin
Director
1.1yrs
€34.00k
no data
Martin Duvall
Director
1.1yrs
€41.50k
no data
Sally Bennett
Independent Director
1.1yrs
€85.00k
0.0027% € 4.0k
Irina Staatz-Granzer
Independent Chairwoman of the Board
1.1yrs
no data
0.027% € 40.5k
Pascale Boissel
Independent Vice Chairperson of the Board
1.1yrs
€89.50k
0.0011% € 1.6k
Veronique Chabernaud
Independent Director
1.1yrs
€79.00k
0.00070% € 1.1k
Katy Rezvani
Strategic Advisory Board Member
2.4yrs
no data
no data
Aurelien Marabelle
Strategic Advisory Board Member
7.6yrs
no data
no data
1.1yrs
Average Tenure
61yo
Average Age
Experienced Board: IDD's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/01 08:23
End of Day Share Price
2026/05/27 00:00
Earnings
2025/12/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Innate Pharma S.A. is covered by 13 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.